adagiotx.gcs-web.com Open in urlscan Pro
2a02:26f0:f500:6::216:5bd3  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content
Invivyd Logo
 * About
   * Mission
   * Leadership Team
   * Board of Directors
   * Partnerships
 * Platform
   * Overview
   * Scientific Publications
 * Pipeline
   * Overview
   * COVID-19
   * Influenza
   * Clinical Trials
 * Product
 * Investors & Media
   * Overview
   * Press Releases
   * Events & Presentations
   * Analyst Coverage
   * Stock Information
   * Financials & Filings
   * Corporate Governance
   * Scientific Publications
   * Resources
 * Careers
   * Our Culture & Values
   * Open Positions
 * Contact Us





toggle navigation
Tenaciously
WORKING TO FIGHT VIRAL THREATS


INVESTOR OVERVIEW

Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to
delivering protection from serious viral infectious diseases, beginning with
SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines
state-of-the-art viral surveillance and predictive modeling with advanced
antibody engineering. INVYMAB is designed to facilitate the rapid, serial
generation of new monoclonal antibodies (mAbs) to address evolving viral
threats. In March 2024, Invivyd received emergency use authorization (EUA) from
the U.S. FDA for its first mAb in a planned series of innovative antibody
candidates.


LATEST NEWS

May 31, 2024

Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient
Emergency Use Authorization Pathway for the Prevention and Treatment of
Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and
Immunobridging for Serial Monoclonal Antibodies

May 31, 2024

Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer

May 29, 2024

Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO)
Annual Meeting and 2024 American Transplant Congress (ATC)

All Press Releases


EVENTS

More events are coming soon.
All Events


Print
Contact IR
RSS
Email Alerts
Invivyd Logo

FOR MEDICAL INFORMATION: medinfo@invivyd.com
800.890.3385
Monday-Friday,
9:00 AM to 7:00 PM ET

FOR ADVERSE EVENTS: PV@invivyd.com

FOR GENERAL INFORMATION: info@invivyd.com

INVIVYD HEADQUARTERS:
1601 Trapelo Rd., Suite 178
Waltham, MA 02451
781.819.0080

linkedin twitter
Privacy Policy
Terms of Use
Cookie Policy
©2024 Invivyd, Inc. Invivyd, Invymab and the Invivyd logo are trademarks of
Invivyd, Inc. All rights reserved.